Harald Schmidt

With a double degree in Medicine and Pharmacy, Harald Schmidt has a passion for systems medicine, i.e. to re-define what we call “disease” from a descriptive symptom-based to a mechanism-based approach by using big data, innovative target validation and rapid repurposing of registered drugs for new clinical applications. As an ERC proof-of-concept investigator he follows up on his ERC Advanced Grant to perform high risk/high potential benefit research in areas of major medical need, such as the development and commercialisation of a first-in-class neuro-protective therapy in stroke. He chairs the COST action OpenMultiMed contributing to the Big Data-based evolution of Medicine, coordinates the H2020 project REPO-TRIAL and leads the clinical work packet in the H2020 programme FeatureCloud.

Together with Jan Baumbach he is co-editor-in-chief of the 2018 founded journal Systems Medicine. His multi-national (Germany, USA, Australia, Netherlands) research experience in Academia, Industry (Abbott) and Biotech (Vasopharm) has led to high impact publications (Hirsch 85) with high socio-economic relevance such as drug and diagnostics patents, spin-offs and patient benefit. He is a dedicated teacher and supports enthusiastic young researchers to achieve leadership positions themselves.

Please feel free to share this...